Development of Combined Nano-Bio Technology for Remediation of Chromium Contamination
Public support
Provider
Technology Agency of the Czech Republic
Programme
Programme of applied research and experimental development ALFA
Call for proposals
ALFA 1 (STA02011TA01)
Main participants
ENACON s.r.o.
Contest type
VS - Public tender
Contract ID
20110190
Alternative language
Project name in Czech
Vývoj kombinované technologie nano-bio k sanaci znečištění chrómem
Annotation in Czech
Cílem projektu je vývoj a ověření kombinované technologie Nano-bio pro sanaci horninového prostředí kontaminovaného hexavalentním chrómem. Výstupem bude technologický postup zahrnující stanovení abio- a bio- redukčních činidel, resp. substrátů, jejich dávkování a předúpravy. Součástí postupu bude i popis sanačních parametrů a jejich kritických hodnot a hydrogeologická a geochemická charakteristika lokalit, na nichž je metoda uplatnitelná.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
DK - Contamination and decontamination of soil including pesticides
CEP - secondary branch
DJ - Pollution and water control
CEP - another secondary branch
EI - Biotechnology and bionics
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
10511 - Environmental sciences (social aspects to be 5.7)<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
Outputs and results were achieved in accordance with the Contract / Decision on the Provision of Targeted Support, resp. of the current Amendment to this Agreement.
Solution timeline
Realization period - beginning
Jan 1, 2011
Realization period - end
Jun 30, 2015
Project status
U - Finished project
Latest support payment
Mar 7, 2014
Data delivery to CEP
Confidentiality
C - Předmět řešení projektu podléhá obchodnímu tajemství (§ 504 Občanského zákoníku), ale název projektu, cíle projektu a u ukončeného nebo zastaveného projektu zhodnocení výsledku řešení projektu (údaje P03, P04, P15, P19, P29, PN8) dodané do CEP, jsou upraveny tak, aby byly zveřejnitelné.
Data delivery code
CEP16-TA0-TA-U/02:3
Data delivery date
Aug 14, 2019
Finance
Total approved costs
14,418 thou. CZK
Public financial support
11,026 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
3,539 thou. CZK